Loading provider…
Loading provider…
Hematology & Oncology Physician in San Francisco, CA
NPI: 1225320310HQ Phone
Get Mallika's Phone Numberphone_androidMobile
Get Mallika's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2014 - 2026
NC State Medical License
2011 - 2014
UC San Diego School of Medicine
medschool.ucsd.edu
Medical School
Until 2011
Duke University Hospital
Residency • Internal Medicine
2011 - 2014
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Hematology and Medical Oncology
2014 - 2017
University of California, San Diego
B.S. • Bioengineering
2002 - 2006
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.
Authors: Michelle Melisko, Amy Chien, Mark Moasser, Hope Rugo
Publication Date: 2020-07
Authors: Steven Garfin, Yu-Po Lee, Choll Kim
Journal: Spine (Phila Pa 1976)
Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.
Authors: Tian Zhang, Mallika Dhawan, Patrick Healy, Daniel George, Michael Harrison, Jorge Oldan, Bennett Chin, Andrew Armstrong
Publication Date: 2014-12-10
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Olaparib, BIOLOGICAL: Ramucirumab
Lead Sponsor: University of California, San Francisco
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Questionnaires, PROCEDURE: Magnetic Resonance Cholangiopancreatography, PROCEDURE: Endoscopic ultrasound
Lead Sponsor: JS InnoPharm, LLC
Intervention / Treatment: DRUG: Dabrafenib, DRUG: JSI-1187